# Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients

> **NCT05217719** · PHASE4 · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 178 (estimated)

## Conditions studied

- Pneumonia
- Thrombocytopenia

## Interventions

- **DRUG:** recombinant human thrombopoietin
- **DRUG:** normal saline

## Key facts

- **NCT ID:** NCT05217719
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02
- **Primary completion:** 2023-08
- **Final completion:** 2023-10
- **Target enrollment:** 178 (ESTIMATED)
- **Last updated:** 2022-02-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05217719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05217719, "Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05217719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*